SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-020269
Filing Date
2020-01-31
Accepted
2020-01-31 06:36:11
Documents
14
Period of Report
2020-01-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d856413d8k.htm   iXBRL 8-K 30232
2 EX-99.1 d856413dex991.htm EX-99.1 308781
6 GRAPHIC g856413g0130234823438.jpg GRAPHIC 2155
  Complete submission text file 0001193125-20-020269.txt   493441

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idxx-20200131.xsd EX-101.SCH 3061
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20200131_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20200131_pre.xml EX-101.PRE 10947
12 EXTRACTED XBRL INSTANCE DOCUMENT d856413d8k_htm.xml XML 3325
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

IRS No.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 20563254
SIC: 2835 In Vitro & In Vivo Diagnostic Substances